Background and objective: Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) has emerged as a minimally invasive technique for diagnosing intrathoracic malignancies and some benignancies; however, there are no data available on the utility of EBUS-TBNA for the diagnosis of non-specific inflammatory intrathoracic lymphadenitis.
Conclusions: EBUS-TBNA can provide pathological and microbiological evidences for diagnosing non-specific inflammatory intrathoracic lymphadenopathy, and it is a safe and effective first-line investigation for ruling out malignancies and other benign diseases.
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| I NTR ODU CTI ON
Enlargement of mediastinal/hilar lymph nodes (LNs) can be caused by malignancies, and is more commonly associated with benign diseases.
1,2 Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) has emerged as a useful technique for evaluating medaistinal/hilar lymphadenopathy since invented, including diagnosing and staging of lung cancer, diagnosis of mediastinal malignancies as well as some specific benign diseases, such as sarcoidosis and tuberculosis (TB), because it is a minimally invasive procedure that is generally available, easy to use and with minimal additional costs. [3] [4] [5] [6] [7] [8] [9] Less is known, however, about the utility of EBUS-TBNA for diagnosing non-specific intrathoracic inflammatory lymphadenopathy. Pathology and microbiology play distinct roles in diagnosing non-specific intrathoracic lymphadenitis. Lymphoma, TB, sarcoidosis as well as fungal infection have overlapping clinical or diagnostic features with that of non-specific intrathoracic lymphadenitis, differential diagnosis is a common dilemma encountered by pathologists and clinicians in clinical practice, because these diseases have completely different therapeutic regimens. Thus, distinguishing non-specific inflammation from malignancy and other specific benignancies is extremely important for developing suitable treatment plan. However, the main controversy is whether EBUS-TBNA could provide effective evidences for diagnosing non-specific intrathoracic lymphadenitis? This study concentrated on the EBUS-TBNA pathological features and microbiological tests that help distinguish non-specific intrathoracic lymphadenitis from malignancies and other specific benign diseases. To our knowledge, this is the first study to discuss the value of EBUS-TBNA for diagnosing non-specific inflammation.
| M A TERI ALS AN D M ETH OD S

| Patients
We prospectively enrolled patients with undetermined intrathoracic lymphadenopathy suspect of non-specific intrathoracic lymphadenitis who underwent EBUS-TBNA from October 2009 to March 2012 in Shanghai Chest Hospital.
Patients were included in the study by the following guidelines: (i) presence of enlarged mediastinal/hilar LNs (at least one node > 1 cm in short-axis) based on computerized tomography (CT) or positive intrathoracic lymph nodes detected (defined as standardized uptake value >2.5) by positron emission tomography (PET) within reach of the convex probe for EBUS-TBNA; (ii) patients suspected of lymphadenitis requiring EBUS-TBNA for distinguishing inflammation from malignancies and other benignancies in order to obtain definite diagnosis and further guide the systemic therapy, and in whom routine medical work-up had failed to achieve a diagnosis were prospectively enrolled into the study; (iii) no history of malignancies and other benign diseases (sarcoidosis, TB, fungal infection, connective tissue disease, etc.) by reviewing the patient's clinical data; ( ) informed consent signed for an EBUS-TBNA examination and no contraindication to the procedure. Patients were excluded from the study if there was other diagnosis being defined. The protocol was approved by the Ethics Committee of Shanghai Chest Hospital (KS10-03).
| EBUS-TBNA procedure
EBUS-TBNA was performed with the patient under moderate sedation (midazolam) and local anesthesia (lidocaine), as we described previously. 10, 11 After oral bronchoscopy, target
LNs and peripheral vessels were examined by EBUS, using a linear array ultrasonic bronchoscope (BF-UC 260F-OL8, Olympus Ltd, Tokyo, Japan). Scanning was performed at the frequency of 7.5 MHz and images were processed by an Olympus ultrasound processor (EU-C2000; Olympus Ltd). LNs classification was based on the international staging system. 12 The diameters of target LN were measured and recorded under frozen ultrasound image. A dedicated 22-gauge needle was used for aspiration (NA-201SX-4022; Olympus Ltd). Three needle aspirations were performed for each target lymph node. However, if a visible histologic core was obtained, two aspirations were acceptable. Rapid on-site cytological evaluation (ROSE) was not performed. Cytological smears stained by hematoxylin and eosin (HE) were delivered to two pathologists blinded to subject details. Aspirated material was formalin-fixed and paraffin-embedded before being examined by light microscopy. Microbiological tests (gram staining for bacteria and fungi, special staining for acid-fast bacilli, as well as culture for bacteria, fungi, and mycobacterium TB) were performed in all patients.
| Data collection and outcome
Collected data included target location, target diameter, aspiration times per lesion, and complications. Microbiological and pathological diagnoses by EBUS-TBNA as well as the final diagnoses were also reviewed. White-light bronchoscopic findings (WLB) were divided into 4 categories: (i) no endobronchial lesions; (ii) extrinsic compression without mucosal change; (iii) submucosal lesions (erythema, edema, mucosal thickening, bronchial narrowing, bleeding, or mucosa eminence); and (iv) exophytic lesions. 7 If an endobronchial lesion was seen, an endobronchial biopsy for pathology detection or bronchial brushings and washings for microbiologic detection were also performed according to the operators' judgment.
A specimen was considered adequate if there were multiple lymphocyte clusters present from target LNs. Specimens with substantive red blood cells and broken bronchial epithelium, tracheal cartilage or very few nucleated cells were defined inadequate. EBUS-TBNA specimens of LNs showing specific manifestationos of inflammation with no malignancy or other specific diagnosis evidences were defined as "positive." Pathologies of non-specific intrathoracic lymphadenitis were categorized into three kinds: (i) inflammatory infiltrates and/or noncaseating necrosis; (ii) granuloma formed by epithelioid cells and/or fiber hyperplasia; (iii) lymph node tissue/lymphocyte without obvious abnormal lesions. For the specimens showing inflammatory infiltrates along with granuloma or fiber hyperplasia were classified as first kind of pathology.
EBUS-TBNA diagnosis was subsequently confirmed by results of another pathological examination involving thoracotomy, mediastinoscopy, thoracoscopy, repeating EBUS-TBNA (Re-EBUS-TBNA), CT-guided transthoracic needle aspiration (CT-TTNA), and conventional bronchoscopy. When EBUS-TBNA pathology is controversial and especially inconsistent with clinical diagnosis, further invasive methods were considered. All patients received at least 2 years clinical follow-up.
| Statistical analysis
Data was calculated according to standard definitions by using the software package SPSS 11.5 (SPSS Inc., Chicago, IL). The data of continuous variables are presented as mean 6 SD. Univariate analyses assessed the independent risk factors for pathology types of inflammation. A t-test was used for comparison of continuous variables and the v 2 test, or Fisher's exact test, when appropriate, for used for categorical variables. Significance was considered for a P value < .05, and all analyses were two-sided. Comparisons between multiple groups were performed by one-way analysis of variance procedures, followed by the LSD post hoc test for intergroup comparisons. 
| R ES ULTS
| EBUS-TBNA results
We performed EBUS-TBNA on 191 lesions in 94 patients with non-specific intrathoracic lymphadenitis (flowchart shown in Figure 1 ). Locations, diameters of target lesions, and average aspiration times per target lesion are shown in Table 2 . Fifty-six patients (59.6%) had two or more LN stations being sampled. No procedure-related complication was observed other than minor puncture site bleeding noted endoscopically. Ninety-two patients were classified into three groups based on above EBUS-TBNA pathology types of nonspecific inflammatory intrathoracic lymphadenitis. Inflammatory infiltrates and/or noncaseating necrosis, being the characteristics of acute inflammation, existed in 38 cases with acute lymphadenitis (Figure 2a-c) or acute phase of chronic lymphadenitis (Figure 2d-f) . Of these 38 cases, there was one patient being confirmed by thoracoscopy and two patients underwent a repeating EBUS-TBNA with pathological result consistent with initial diagnosis of first EBUS-TBNA. Granuloma formed by epithelioid cells and/or fiber hyperplasia existed in 13 cases with chronic lymphadenitis (Figure 2g-i) . Lymph node tissue/lymphocyte without obvious abnormal lesions existed in 41 cases, being considered as partial pathology performance of reactive hyperplasia in chronic lymphadenitis or failure in obtaining distinctive FIGU RE 1 Flowchart of 94 patients with non-specific intrathoracic lymphadenitis undergoing endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) specimen of inflammation (Figure 2j-l) , three mediastinoscopy and two thoracotomy pathologies further confirming LN reactive hyperplasia. Unqualified biopsy sample occurred in two cases being diagnosed chronic lymphadenitis by excluding malignancy, TB, and sarcoidosis through EBUS-TBNA smears, as well as brushings and washings under conventional brochoscopy. Furthermore, both diagnoses of these two cases were further confirmed by at least 2 years clinical follow-up, showing no progression of clinical and CT findings. In 92 patients with qualified specimen for diagnosing inflammation, there was no significant relation between pathology and LN region (P 5 .83), significant difference between first two and third kind of pathology was detected in LN short-axis diameter (P 5 .03), but not in long-axis diameter, aspiration times per lesion (Table 3) .
Microbiological tests were carried out in all 94 (100%) patients. All patients (100%) underwent acid-fast staining and culture of mycobacterium TB to exclude TB, with no FIGU RE 2 EBUS-TBNA pathology of non-specific intrathoracic lymphadenitis. a-c: Acute lymphadenitis diagnosed by EBUS-TBNA in 29-year-old male. Chest CT demonstrates lower right lung mass and 7 lymph node (LN) enlargement (a). EBUS images of real-time measurement of 7 LN (b). TBNA histopathology showed inflammatory infiltrates and necrotic tissue (c, 340). d-f: Acute phase of chronic lymphadenitis diagnosed by EBUS-TBNA in 71-year-old male. Chest CT demonstrates 7 LN enlargement and pleural effusion (d). EBUS images of real-time measurement of 7 LN (e). TBNA histopathology showed inflammatory infiltrates and fiber hyperplasia (f, 340). g-i: Chronic lymphadenitis diagnosed by EBUS-TBNA in 59-year-old male. Chest CT showed 4R LN enlargement (g). EBUS images of real-time measurement of 4R LN (h). TBNA histopathology of target lesion showed lymphocytes and epithelioid cells (i, 3 20) . j-l: Chronic lymphadenitis diagnosed by EBUS-TBNA in 48-year-old male. Chest CT showed mediastinal/hilar LN enlargement, with increased FDG-uptake suspect lymphoma (j). EBUS images of real-time measurement of 7 LN (k). TBNA histopathology of target lesion showed lymphocytes being found in blood clot (l, 3 20) . Mediastinoscopy pathology showed chronic lymphadenitis TB evidences being detected. Bacterial and/or fungal smears and cultures were carried out in all 94 patients, with growth of streptococcus viridans in 2 patients, Pseudomonas aeruginosa in 1 patient, Stenotrophomonas maltophilia in 1 patient, and oropharyngeal engraftment bacteria in other 90 patients.
All patients being diagnosed non-specific intrathoracic lymphadenitis received antibiotic treatment as deemed necessary and underwent at least 2 years close follow-up, showing no evidences inconsistent with initial diagnosis.
| D ISCU SSI ON
The utility of EBUS-TBNA in the diagnosis of non-specific inflammation in our study was satisfactory, with 97.9% (92/ 94) patients having effective histological specimens for diagnosis. Our prospective analysis showed that specimens with inflammatory infiltrates and/or noncaseating necrosis often occurred in acute lymphadenitis or acute phase of chronic lymphadenitis; granuloma formed by epithelioid cells and/or fiber hyperplasia mainly provided pathological evidence for patients with chronic lymphadenitis; LN tissue/lymphocyte without obvious abnormal lesions often can be considered as either EBUS-TBNA pathological features of reactive hyperplasia in chronic lymphadenitis or failure in obtaining characteristic pathological specimen of inflammation in condition of excluding malignancy such as lung cancer, lymphoma, thymoma, and so on.
Due to the prevalence of TB, 7,13 patients with granulomatous inflammation of pathology diagnosis were often being prescribed diagnostic anti-TB therapy. However, such patients may also clinically improve spontaneously and be classed inappropriately as responders to anti-TB treatment. It should also be noted that granulomatous inflammation may be included in the differential considerations. TB is most common cause in infectious granulomas, but is not the only reason. In this study, granuloma without caseation was found in 13 cases. The 13 patients did not carry out diagnostic anti-TB, anti-fungal, or glucocorticoid treatment, with no progression of clinical symptoms and radiographic findings in subsequent follow-up. So we consider granuloma/fiber hyperplasia, may be the result of non-specific pathogen chronic inflammatory stimulation in these patients, which was consistent with previous opinion on epithelioid granuloma could be seen in inflammation.
14 There were studies show that EBUS-TBNA could be useful in diagnosing lymphoma with sensitivity arrange from 76% to 90.9%, 4, 15 however, recent research reported that reactive LN diagnosed by EBUS-TBNA was confirmed as lymphoma by thoractomy. 16 More biopsy specimens, flow cytometry and immunohistology could help raise diagnostic yield of EBUS-TBNA for lymphoma. For 41 patients showing LN tissue/lymphocyte without obvious abnormal lesions in our study, during at least 2 years clinical follow-up, all patients received no anti-TB, anti-fungal, or glucocorticoid treatment, no evidence of lymphoma development and no progression of clinical and radiologic findings being found in all patients.
It is recommended that all LNs negative on EBUS-TBNA biopsy had to perform more invasive examination for further confirmation, because of the unacceptably high falsenegative rate. 17, 18 Most specimens showing LN tissue/lymphocyte without obvious abnormal lesions were being considered as "false-negative" traditionally, however, this pathology should be divided into three situations in our opinion. First, this pathology was actually partial performance of reactive hyperplasia, which was a pathological feature for chronic lymphadenitis. Compared with surgical resection histology, small tissue core specimen of EBUS-TBNA might not reflect the whole LN view, only showing LN tissue/lymphocyte without obvious abnormal lesions. Another possibility was target LN not being involved in inflammation (normal LN). The last was failure of EBUS-TBNA (falsenegative for inflammation), that is specimen with inflammation pathological characteristics not being distinguished. Generally, when EBUS-TBNA specimens were deemed qualified, the first situation was accepted by us for providing evidences of diagnosing chronic lymphadenitis. Statistical analysis results showed that there was no significant relation between pathology and LN region (P 5 .83), while significant difference in LN short-axis diameter being detected between first two and third kind of pathology (P 5 .03), which might prove that distinctive pathology of inflammation often being aspirated from larger diameter LNs, similar conclusions have been detected in our previous studies. 7, 19 These analysis results further confirmed our opinion that LNs with third pathology were smaller because they are chronic lymphadenitis or normal LNs. Besides identifying the pathological features of lymphadenitis, ruling out fungi infection, and TB by microbiological results is necessary, especially for specimens showing noncaseating necrosis or granuloma, avoiding unnecessary antifungal or glucocorticoid treatment. In this situation, acid-fast staining and culture for mycobacterium TB as well as bacterial/fungal smears and cultures should be carried out to provide complementary evidence for diagnosis of lymphadenitis. The first aspiration specimens are precious for bacterial and/or fungal smears and cultures, and culture is the most reliable method for identifying organisms. However, prior antibiotic treatment often carried out in patients before EBUS-TBNA and paucibacillary nature of LN may induce relative lower rate of positive bacteria cultures in EBUS-TBNA specimens, in this condition, excluding TB is more essential than identifying organisms, especially in our high TB-burden country. 7, 13 All 94 patients in our study underwent bacterial and/or fungal smears and cultures, pathogens were only found in 4 (4.3%) cases, with oropharyngeal engraftment bacteria showing in other 90 patients. Steinfort et al. 20 reported that needle samples by EBUS-TBNA had higher rate of oropharyngeal engraftment bacteria pollution and lower rate of positive bacteria cultures which was consistent with the data of our research. The limitations of the study must be acknowledged. Firstly, ROSE is not adapted, which has been proved effective for guaranteeing enough samples for definite diagnosis and avoiding unnecessary examination. ROSE also probably reduces the number of punctured LNs. 21 When malignancies (lymphoma, thymoma, or metastatic carcinoma) or granulomatous diseases (sarcoidosis or TB) were suspected by cytologist, ROSE could guide operator to get more specimens for further pathological examinations and microbiological tests. Secondly, we should admit that small specimen obtained by EBUS-TBNA might not reflect the full pathology of target lesion and not all patients received surgical procedure to confirm the final pathology of non-specific inflammation, but 2 years clinical follow-up further provided definite diagnoses. Thirdly, this study was carried out in special hospital for chest diseases, most patients have received antibiotic therapy in primary hospitals prior to visiting our hospital, most acute inflammation might have turned into chronic inflammation, inducing proportion of first pathology type lower than the other two types and lower rate of microbacterial culture; although there is at least one node greater than 1 cm in short-axis in included patients, and 56 patients (59.6%) had two or more LN stations being sampled, some normal LNs might be aspirated and be classified as reactive lymphadenitis, inducing the proportion of third pathology type is relatively high. In addition, obtaining high quality specimens is essential for diagnosis of non-specific lymphadenitis, because blood clot with scattered neutrophils in EBUS-TBNA specimens may interfere with pathologist's decision. Therefore, distinguishing inflammatory exudate neutrophils from those background components by experienced pathologist is an important step.
In conclusion, EBUS-TBNA is a safe and effective firstline investigation which can provide pathological and microbiological evidences for diagnosing non-specific intrathoracic lymphadenitis. Moreover, to some extent, reducing of EBUS-TBNA false-negative rate and avoidance of unnecessary surgical procedures is possible.
